Dr. Kitture'S Eureka Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-12-2024
- Paid Up Capital ₹ 0.50 M
as on 27-12-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.60 Cr
as on 27-12-2024
- Revenue 179.04%
(FY 2022)
- Profit 358.56%
(FY 2022)
- Ebitda 368.73%
(FY 2022)
- Net Worth 55.73%
(FY 2022)
- Total Assets 255.27%
(FY 2022)
About Dr. Kitture'S Eureka Diagnostic
The Corporate was formerly known as Vision C T Scan Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.60 Cr.
Balkrishna Kitture and Sharmila Kitture serve as directors at the Company.
- CIN/LLPIN
U85110PN2002PTC017067
- Company No.
017067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Kitture'S Eureka Diagnostic?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balkrishna Kitture  | Director | 16-Jul-2002 | Current |
| Sharmila Kitture | Director | 17-Jul-2021 | Current |
Financial Performance of Dr. Kitture'S Eureka Diagnostic.
Dr. Kitture'S Eureka Diagnostic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 179.04% increase. The company also saw a substantial improvement in profitability, with a 358.56% increase in profit. The company's net worth Soared by an impressive increase of 55.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Kitture'S Eureka Diagnostic?
In 2020, Dr. Kitture'S Eureka Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eureka Diagnostic And Research Centre Private LimitedActive 13 years 5 monthsBalkrishna Kitture and Sharmila Kitture are mutual person
Charges (Loans)
₹36.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.15 Cr
- Bank Of Baroda : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2022 | Hdfc Bank Limited | ₹3.15 Cr | Open |
| 31 Jul 2002 | Bank Of Baroda | ₹4.50 M | Open |
How Many Employees Work at Dr. Kitture'S Eureka Diagnostic?
Unlock and access historical data on people associated with Dr. Kitture'S Eureka Diagnostic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Kitture'S Eureka Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Kitture'S Eureka Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
